MX2019009367A - Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneración de tejidos, organogénesis y función para múltiples tejidos. - Google Patents

Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneración de tejidos, organogénesis y función para múltiples tejidos.

Info

Publication number
MX2019009367A
MX2019009367A MX2019009367A MX2019009367A MX2019009367A MX 2019009367 A MX2019009367 A MX 2019009367A MX 2019009367 A MX2019009367 A MX 2019009367A MX 2019009367 A MX2019009367 A MX 2019009367A MX 2019009367 A MX2019009367 A MX 2019009367A
Authority
MX
Mexico
Prior art keywords
falc
tissue
ectopic
compositions
associated lymphoid
Prior art date
Application number
MX2019009367A
Other languages
English (en)
Spanish (es)
Inventor
Lagasse Eric
Original Assignee
Univ Pittsburgh Commonwealth Sys Higher Education
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Pittsburgh Commonwealth Sys Higher Education filed Critical Univ Pittsburgh Commonwealth Sys Higher Education
Publication of MX2019009367A publication Critical patent/MX2019009367A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/26—Lymph; Lymph nodes; Thymus; Spleen; Splenocytes; Thymocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/22—Urine; Urinary tract, e.g. kidney or bladder; Intraglomerular mesangial cells; Renal mesenchymal cells; Adrenal gland
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/28—Bone marrow; Haematopoietic stem cells; Mesenchymal stem cells of any origin, e.g. adipose-derived stem cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/33—Fibroblasts
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/35—Fat tissue; Adipocytes; Stromal cells; Connective tissues
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/37—Digestive system
    • A61K35/407—Liver; Hepatocytes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00—Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cell Biology (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Urology & Nephrology (AREA)
  • Physiology (AREA)
  • Nutrition Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Hematology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Materials For Medical Uses (AREA)
MX2019009367A 2017-02-17 2018-02-20 Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneración de tejidos, organogénesis y función para múltiples tejidos. MX2019009367A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762460267P 2017-02-17 2017-02-17
US201762574119P 2017-10-18 2017-10-18
PCT/US2018/018684 WO2018152488A1 (en) 2017-02-17 2018-02-20 Fat-associated lymphoid clusters as sites for transplantation,tissue regeneration, organogenesis and function for multiple tissues

Publications (1)

Publication Number Publication Date
MX2019009367A true MX2019009367A (es) 2019-10-24

Family

ID=63170490

Family Applications (2)

Application Number Title Priority Date Filing Date
MX2019009367A MX2019009367A (es) 2017-02-17 2018-02-20 Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneración de tejidos, organogénesis y función para múltiples tejidos.
MX2024005097A MX2024005097A (es) 2017-02-17 2019-08-06 Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneracion de tejidos, organogenesis y funcion para multiples tejidos.

Family Applications After (1)

Application Number Title Priority Date Filing Date
MX2024005097A MX2024005097A (es) 2017-02-17 2019-08-06 Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneracion de tejidos, organogenesis y funcion para multiples tejidos.

Country Status (12)

Country Link
US (2) US20190374583A1 (cg-RX-API-DMAC7.html)
EP (1) EP3582794B1 (cg-RX-API-DMAC7.html)
JP (3) JP2020508298A (cg-RX-API-DMAC7.html)
KR (2) KR102762505B1 (cg-RX-API-DMAC7.html)
CN (2) CN119097642A (cg-RX-API-DMAC7.html)
AU (1) AU2018221254B2 (cg-RX-API-DMAC7.html)
BR (1) BR112019016965A2 (cg-RX-API-DMAC7.html)
CA (1) CA3052295A1 (cg-RX-API-DMAC7.html)
ES (1) ES3070490T3 (cg-RX-API-DMAC7.html)
IL (2) IL268389B2 (cg-RX-API-DMAC7.html)
MX (2) MX2019009367A (cg-RX-API-DMAC7.html)
WO (1) WO2018152488A1 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4427813A3 (en) * 2019-04-11 2024-12-18 University of Pittsburgh- Of the Commonwealth System of Higher Education Minimally invasive cell transplant procedure to induce the development of in vivo organogenesis
WO2023076279A1 (en) * 2021-10-25 2023-05-04 Satellite Biosciences, Inc. Engineered tissue constructs for the treatment of crigler-najjar syndrome
CN116925997B (zh) * 2023-07-27 2024-04-02 湖北医药学院 左氧氟沙星在制备促进细胞增殖中的药物的用途

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6312691B1 (en) 1996-01-26 2001-11-06 Jeffrey L. Browning Lymphotoxin-α/β complexes and anti-lympotoxin-β receptor antibodies as anti-tumor agents
ATE371018T1 (de) * 2001-06-22 2007-09-15 Stemcells Inc Le-zellen (liver engrafting cells), assays und verwendungen davon
US9125891B2 (en) * 2008-03-07 2015-09-08 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph nodes as a site for regeneration
WO2014138486A1 (en) * 2013-03-06 2014-09-12 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
US11191785B2 (en) * 2008-03-07 2021-12-07 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Lymph node as a site for transplantation, organogenesis and function for multiple tissues and organs
AU2012352454A1 (en) * 2011-12-15 2014-07-17 The University Of Chicago Methods and compositions for cancer therapy using mutant light molecules with increased affinity to receptors

Also Published As

Publication number Publication date
JP7784392B2 (ja) 2025-12-11
KR20250020727A (ko) 2025-02-11
MX2024005097A (es) 2024-05-15
IL268389A (en) 2019-09-26
EP3582794C0 (en) 2026-04-22
JP2025176014A (ja) 2025-12-03
JP2023061960A (ja) 2023-05-02
IL310219A (en) 2024-03-01
US20240091271A1 (en) 2024-03-21
IL310219B1 (en) 2026-03-01
CA3052295A1 (en) 2018-08-23
ES3070490T3 (en) 2026-06-16
WO2018152488A1 (en) 2018-08-23
US20190374583A1 (en) 2019-12-12
AU2018221254B2 (en) 2025-03-20
EP3582794B1 (en) 2026-04-22
BR112019016965A2 (pt) 2020-04-14
EP3582794A4 (en) 2020-12-09
CN119097642A (zh) 2024-12-10
CN110869032B (zh) 2024-08-23
KR20190116439A (ko) 2019-10-14
IL268389B2 (en) 2024-06-01
IL268389B1 (en) 2024-02-01
EP3582794A1 (en) 2019-12-25
CN110869032A (zh) 2020-03-06
AU2018221254A1 (en) 2019-08-15
KR102762505B1 (ko) 2025-02-03
IL310219B2 (en) 2026-07-01
JP2020508298A (ja) 2020-03-19

Similar Documents

Publication Publication Date Title
ECSP20077518A (es) Compuestos inhibidores de rip1 y métodos para preparar y usar los mismos
PH12020552060A1 (en) Active agents and methods of their use for the treatment of metabolic disorders and nonalcoholic fatty liver disease
CL2017003436A1 (es) Compuestos de benzoxacepina oxazolidinona y métodos de uso
PE20170324A1 (es) Anticuerpos dirigidos contra cd127
CO2017003070A2 (es) Tetrahidro-pirido[3,4-b]indoles moduladores de receptores de estrógenos y usos de los mismos
EA202091219A1 (ru) Культивирование плаценты с целью выделения экзосом
PE20221914A1 (es) Compuestos de benzaldehido sustituidos y metodos para su uso en incrementar la oxigenacion del tejido
MX2019007144A (es) Nuevos agonistas de tnfr y sus usos.
MX2018009752A (es) 1,2,3,-triazoles sustituidos como moduladores de nmda selectivos de nr2b.
ECSP12011720A (es) Compuestos heterocíclicos y usos de los mismos
ECSP14026271A (es) Compuestos de indol e indazol que activan la ampk
CL2011001263A1 (es) Compuestos derivados de pirimidinonas opcionalmente sustituidas; composicion farmaceutica que los comprende; y su uso como inhibidores de fosfodiesterasa 1 (pde1) para el tratamiento de enfermedades que involucran trastornos de la trayectoria intracelular del receptor de dopamina d1 como parkinson, alzheimer, depresion, enfermedad bipolar, hipertension, glaucoma.
ECSP077421A (es) Compuestos y composiciones como inhibidores de la actividad del receptor canabinoide 1
EA200901166A1 (ru) Соединения и композиции в качестве модуляторов активности gpr 119
UY32880A (es) Nuevos derivados de tiaziazol
UY38377A (es) Piridazinonas y sus métodos de uso
MX2021015500A (es) Pirazolo-pirazinas sustituidas y su uso como moduladores del receptor glun2b.
ECSP109870A (es) Compuestos derivados de alquinil fenilo para tratar enfermedades y desórdenes oftálmicos
CR8992A (es) Analogos de biaril piperazinilpiridina sustituida
PH12015501955B1 (en) Heterocyclic compounds and use thereof as modulators of type iii receptor tyrosine kinases
CO2017006032A2 (es) Métodos para tratar la calcificación de tejidos
MX2024005097A (es) Grupos linfoides asociados al tejido graso como sitios de trasplante, regeneracion de tejidos, organogenesis y funcion para multiples tejidos.
CO2017002312A2 (es) Compuestos bicíclicos sustituidos
MX2017005163A (es) Composiciones de liberación prolongada de onapristona y métodos.
MX393789B (es) Moduladores de los receptores a3 de adenosina